Drug class in one race
IL-23 p19 drugs for Ulcerative Colitis
12 tracked IL-23 p19 drugs in the Ulcerative Colitis race. The class explanation lives on the IL-23 p19 page; the full indication pipeline across every mechanism is on the Ulcerative Colitis page.
5 approved / phase 41 Phase 34 Phase 22 Phase 1
Head-to-head evidence: JNJ-78934804 vs SOR102 · guselkumab vs JNJ-78934804 · JNJ-78934804 vs mirikizumab · JNJ-78934804 vs picankibart · JNJ-78934804 vs risankizumab · MT-201 vs SOR102